ClinConnect ClinConnect Logo
Search / Trial NCT04715711

Physiological and Thermoregulatory Responses of Body Cooling During Cycling in a Hot Environment

Launched by UNIVERSITY OF CONNECTICUT · Jan 14, 2021

Trial Information

Current as of June 16, 2025

Completed

Keywords

ClinConnect Summary

Design

The study will be completed in the following timeline:

Visit 1: Baseline and VO2max Testing

Vist 2: Metabolic Heat Production Visit

Visit 3-6: Trial 1, 2 ,3, 4

Visit specific information is described below, however, specific data collection protocols for dependent variables and procedures are included below the description of the study design. Participants will be asked to sign a photo/video release form (Appendix H) to be used in research projects, scientific publications/conferences and for educational purposes. Participants may be videoed or photographed while exercising or r...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Cisgender man between the ages of 18-28 years
  • been cleared by the medical monitor for this study
  • VO2max \> 45ml/kg/min
  • Aerobically active (at least 30 minutes of aerobic exercise 4-5 days per week)
  • Exclusion Criteria:
  • Have a current musculoskeletal injury that would limit their physical activity or preclude the participant from walking, jogging, running, sprinting, or cutting.
  • Chronic health problems that affect your ability to thermoregulate (disorders affecting the liver, kidneys or the ability to sweat normally)
  • Fever or current illness at the time of testing
  • History of cardiovascular, metabolic, or respiratory disease
  • A family member died for no apparent reason, had a heart attack, died from heart problems, or sudden death before the age of 50
  • Current musculoskeletal injury that limits their physical activity
  • Currently taking a medication that is known to influence body temperature (amphetamines, antihypertensives, anticholinergics, acetaminophen, diuretics, NSAIDs, aspirin)
  • Identify as cisgender woman, transgender man or transgender woman. Cisgender women, Transgender men, and transgender women are excluded from the current study because the sponsor of the study has requested that this testing be done in physically active cisgender males. It is assumed that they either currently have data on women or transgender women/men to compare this to or have a strategic initiative from a marketing or business perspective that only involves cisgender men.
  • Have a history of heat related illness
  • Throat or gastroesophageal diseases including gastroesophageal reflux disease (aka, GERD) or difficulty swallowing
  • Have any allergies or adverse reactions to the cold (e.g. Cold Uticaria, Raynauds Phenomenon/Disease, or Cryoglobulinanemia)

About University Of Connecticut

The University of Connecticut (UConn) is a leading academic institution committed to advancing health and science through innovative research and education. As a clinical trial sponsor, UConn leverages its extensive resources, including renowned faculty and state-of-the-art facilities, to conduct rigorous studies that contribute to medical knowledge and improve patient care. The university fosters a collaborative environment, engaging multidisciplinary teams to explore novel therapies and interventions across various health-related fields. UConn's dedication to ethical practices and compliance ensures the integrity and reliability of its clinical research, ultimately aiming to enhance health outcomes and address critical challenges in healthcare.

Locations

Storrs, Connecticut, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials